Reasons for performing extemporaneous compounding of medicine | No. = 300, 100% |
---|---|
Unavailability of prepackaged products in the market | 233 (77.7) |
Unavailability of needed dosage regimen (dose, form) (individualized therapy) | 217 (72.3) |
The product was discontinued by the manufacturer | 81 (27) |
To combine two or more active ingredients into one product | 128 (42.7) |
To improve adherence to medications (flavor, taste) | 68 (22.7) |
Allergy to the excipient(s) in the commercially available product | 87 (29) |
Compounded medications are less expensive | 90 (30) |
Ministry of Health encourages compounding | 65 (21.7) |
Improving the stability of the desired product | 61 (20.3) |
Route of administration for compounded medication | |
Oral | 214 (71.3) |
Ophthalmic | 148 (49.3) |
Topical (Skin) | 121 (40.3) |
Parenteral | 89 (29.7) |
Otic | 82 (27.3) |
Rectal | 44 (14.7) |
Nasal | 32 (10.7) |
Inhalation | 24 (8) |
Rectal | 44 (14.7) |
Others | 5 (1.7) |